Top Markets
Coin of the day
Caladrius Biosciences, Inc. Caladrius Biosciences, Inc.

Caladrius Biosciences, Inc.

CLBS
Ранг среди акций #33300
Caladrius Biosciences, Inc. operates as a clinical-stage biopharmaceutical... Caladrius Biosciences, Inc. operates as a clinical-stage biopharmaceutical company primarily engaged in the development and commercialization of cellular therapies. These therapies aim to either reverse various diseases or stimulate the regeneration of compromised tissue. The company's pipeline includes several key investigational therapies: HONEDRA, which has received the prestigious SAKIGAKE designation, is undergoing Phase II clinical trials as a potential treatment for critical limb ischemia; XOWNA is currently in Phase IIb trials targeting coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy, is being evaluated for chronic kidney disease in patients prior to requiring dialysis. Previously known as NeoStem, Inc., the firm adopted its current name, Caladrius Biosciences, Inc., in June 2015. Established in 1980, the company maintains its corporate headquarters in Basking Ridge, New Jersey.
Цена акции
$0.4264
Последняя синхронизация: 2022-09-14
Рыночная капитализация
$7.93M
Изменение (1 день)
-16.44%
Изменение (1 год)
0.00%
Страна
US
Торговля Caladrius Biosciences, Inc. (CLBS)

Категория

История цены акций Caladrius Biosciences, Inc. (CLBS)
Наивысшая цена закрытия: $0.50 2022-09-01

Наименьшая цена закрытия: $20.36 2015-06-01
История цены акций Caladrius Biosciences, Inc. с 2015 по 2026
Годовая динамика цены акций
Год Результативность
2022 -43.51%
2021 -42.36%
2020 -36.52%
2019 -44.38%
2018 26.20%
2017 2.72%
2016 -70.04%
2015 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$511.97 30.34%
US
$984.83 50.62%
NL
$736.38 7.15%
CH
$1.07K -6.40%
KR
$255.62 13.43%
BE